Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-03-08
2005-03-08
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S235800, C514S248000, C514S256000, C514S258100, C514S262100, C514S310000, C514S311000, C514S312000, C514S328000, C514S331000, C514S346000, C514S357000, C514S359000, C514S364000, C514S366000, C514S367000, C514S370000, C514S380000, C514S406000, C514S411000, C514S416000, C514S424000, C514S427000, C514S428000, C514S430000, C514S438000, C514S443000, C514S449000, C514S452000, C514S459000, C514S456000, C514S467000, C514S568000, C514S471000, C514S633000, C514S637000, C544S237000, C544S265000, C544S278000, C544S
Reexamination Certificate
active
06864254
ABSTRACT:
An inhibitor for 20-hydroxyeicosatetraenoic acid production which comprises as the active ingredient a specific hydroxyformamidine derivative or a pharmacologically acceptable salt thereof. It is useful especially as a remedy for kidney diseases, cerebrovascular diseases, or circulatory diseases. The novel hydroxyformamidine derivative or pharmacologically acceptable salt thereof is also provided.
REFERENCES:
patent: 4237168 (1980-12-01), Reifschneider
patent: 4465841 (1984-08-01), Cereda et al.
patent: 5238964 (1993-08-01), Kikuchi et al.
patent: 2543179 (1976-04-01), None
patent: 27 17 437 (1978-10-01), None
patent: 53-132529 (1978-11-01), None
patent: 0 132 881 (1985-02-01), None
patent: WO 9943310 (1999-09-01), None
Zinner et al. (Chem.-Ztg. (1974), 98(3), 159). Abstract.*
Hussein et al. (Bull. Coll. Sci., Univ. Baghdad (1973), 14, 79-87), Abstract.*
International Search Report.
Hayakawa, K. et al., “Quantitative Structure-Activity Relationships of Fungicidal N-Phenylformamidoximes”, J. Pesticide Sci. vol. 17, No. 1, pp. 17-25 (1992).
Alonso-Galicia, M. et al., “Inhibition of 20-HETE Production Contributes to the Vascular Responses to Nitric Oxide”, Hypertension, vol. 29, No. 1, pp.320-325 (1997).
Amada Hideaki
Ishii Takaaki
Kobayashi Yuko
Miyata Noriyuki
Sato Masakazu
Kifle Bruck
Sughrue & Mion, PLLC
Taisho Pharmaceutical Co. Ltd.
LandOfFree
Inhibitor for 20-hete-yielding enzyme does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitor for 20-hete-yielding enzyme, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitor for 20-hete-yielding enzyme will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3391928